SCHEMBL4079724

SCHEMBL4079724

COc1ccc2c(c1)CCN(C1CCN(OC(=O)O)CC1)C(=O)N2

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 1/20 0.40
PDE3A Q14432 1/20 0.40
LCK P06239 1/20 0.40
NOTUM Q6P988 1/20 0.39
PARP1 P09874 1/20 0.38
HTR2C P28335 4/20 0.37
HTR2B P41595 4/20 0.37
DPP4 P27487 1/20 0.37
DPP8 Q6V1X1 1/20 0.37
DPP9 Q86TI2 1/20 0.37
KDM4E B2RXH2 1/20 0.37
KMT2A Q03164 1/20 0.37
FKBP1A P62942 2/20 0.36
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36
HTR2A P28223 2/20 0.36
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4079721 0.87 PDE3B (0.41) PDE3BPDE3ALCKNOTUMPARP1
SCHEMBL1700431 0.85 PDE3B (0.46) PDE3BPDE3APARP1HTR2CHTR2B
SCHEMBL4074982 0.82 CALCRL (0.48)
SCHEMBL1207348 0.82 HTR2C (0.46) PDE3BPDE3APARP1HTR2CHTR2B
SCHEMBL7007849 0.82 PDE3B (0.45) PDE3BPDE3ALCKPARP1HTR2C
SCHEMBL3958975 0.81 CALCRL (0.43) DPP4
SCHEMBL19873878 0.81 HTR2C (0.42) PDE3BPDE3ALCKNOTUMHTR2C
SCHEMBL30178610 0.81 ALDH1A1 (0.51) KDM4EKMT2ATP53
SCHEMBL2921538 0.80 LCK (0.36) PDE3BPDE3ALCKKDM4EKMT2A
SCHEMBL3964416 0.80 ALDH1A1 (0.41) MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2108648-A1 Selected CGRP antagonists, method for their manufacture and use as medicines Boehringer Ingelheim International GmbH (DE) 2009-10-14 EP disclosed
EP-1732917-B1 SELECTED CGRP ANTAGONISTS, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA (DE) 2009-07-29 EP disclosed